Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model

Fig. 7

MSCs-Fstl1 treatment abrogates myocardial infiltration of inflammatory cells in peri-infarct zones. a Representative images of CD68-positive macrophage infiltration within the infarct border zone on post-therapy 7 days. Scale bar = 20 μm. bd qRT-PCR analysis of TNF-α (b), IL-6 (c), and IL-1β (d) in ischemic myocardium on post-therapy 7 days (n = 3–4). **P < 0.01; ***P < 0.001. TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; IL-1β, interleukin-1β; ns, not significant

Back to article page